REDMILE GROUP, LLC – Celldex Therapeutics, Inc. Transaction History
REDMILE GROUP, LLC portfolio value:
$55.80M
portfolio value
REDMILE GROUP, LLC quarter portfolio value change:
+4.27%
quarter
Celldex Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -4.11% | -85.13K shares | -12K | $28.11 | 1.98M |
| Q2 2022 | share | Increase | +1.17% | 24.01K shares | -13.88M | $26.96 | 2.07M |
| Q1 2022 | share | Decrease | -5.51% | -119.31K shares | -13.98M | $34.06 | 2.04M |
| Q4 2021 | share | Decrease | -28.84% | -877.71K shares | -80.63M | $38.9 | 2.16M |
| Q3 2021 | share | Increase | +1.04% | 31.21K shares | 63.58M | $53.99 | 3.04M |
| Q2 2021 | share | Decrease | -11.09% | -375.70K shares | 30.93M | $33.44 | 3.01M |
| Q1 2021 | share | Increase | +24.94% | 676.17K shares | 22.28M | $20.6 | 3.38M |
| Q4 2020 | share | Increase | +36.32% | 722.41K shares | 18.00M | $17.52 | 2.71M |
| Q3 2020 | share | Decrease | -0.54% | -10.8K shares | 3.5M | $14.83 | 1.98M |
| Q2 2020 | share | Increase | 0.00% | 2M shares | 26M | $13 | 2M |